<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04985786</url>
  </required_header>
  <id_info>
    <org_study_id>OD 113/3-1</org_study_id>
    <nct_id>NCT04985786</nct_id>
  </id_info>
  <brief_title>Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia</brief_title>
  <acronym>PathRisk</acronym>
  <official_title>Pathological Risk: Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Konstanz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre for Psychiatry Reichenau, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Konstanz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hyper- or hypo-attribution of risks is deeply related to the core pathological mechanisms&#xD;
      of mental disorders and at the same time engaging in risky behaviors influences their course&#xD;
      and outcomes. The investigators study risk perception, risk behaviors and underlying brain&#xD;
      mechanisms in a longitudinal design in three groups of psychiatric patients who participate&#xD;
      in a psychological intervention that is aimed to reduce risk behavior and increase risk&#xD;
      perception.&#xD;
&#xD;
      Patients with schizophrenia (SZ), alcohol use disorder (AUD) and both disorders (SZ + AUD)&#xD;
      are recruited during psychiatric in-patient treatment and participate in a combined&#xD;
      face-to-face and mobile intervention that starts before release and ends four weeks after&#xD;
      discharge. The standardized 4-session face-to-face group intervention that is based on&#xD;
      motivational interviewing (Miller &amp; Rollnick, 2013) and relapse prevention (Marlatt &amp;&#xD;
      Donovan, 2005) and addresses the reduction of disorder-specific risk behaviors, i.e. alcohol&#xD;
      use for AUD and SZ+AUD and medication non-adherence for SZ. After discharge, a 4-week&#xD;
      ecological momentary intervention (EMI) supports participants to maintain abstinence from&#xD;
      risk behaviors and to strengthen coping in high-risk situations relying on mental contrasting&#xD;
      and implementation intentions (Oettingen &amp; Gollwitzer, 2011). Participants will be assessed&#xD;
      in fMRI and behavioral measurements and by self-report pre and post interventional phase,&#xD;
      furthermore they participate in an ecological momentary assessment during the post-discharge&#xD;
      phase which assesses risk behaviors, high-risk situations and risk perception in real life&#xD;
      contexts.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Nucleus Accumbens activation and connectivity during risky decision making</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change of fMRI signal (BOLD) in Balloon Analogue Risk Task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Engagement in risk behaviors</measure>
    <time_frame>4 weeks</time_frame>
    <description>Alcohol drinking (for AUD and AUD+SZ) and medication non-adherence (for SZ) as recorded by ecological momentary assessment (EMA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk reappraisal</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change of risk perception after critical event depending on the outcome of the critical event (engaging is risk behavior or not) as defined by Klepper et al. (2017)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activation of amygdala, STS, mPFC and insula during risk evaluation</measure>
    <time_frame>6 weeks</time_frame>
    <description>fMRI signal (BOLD) in a trustworthiness task</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Alcohol Use Disorder (AUD)</condition>
  <condition>Schizophrenia and Related Disorders</condition>
  <arm_group>
    <arm_group_label>AUD Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Risk behavior specific intervention, targeting alcohol drinking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AUD Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-risk behavior specific intervention, targeting cognitive exercises</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AUD &amp; SZ Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Risk behavior specific intervention, targeting alcohol drinking</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AUD &amp; SZ Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-risk behavior specific intervention, targeting cognitive exercises</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SZ Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Risk behavior specific intervention, targeting medication non-adherence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SZ Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-risk behavior specific intervention, targeting cognitive exercises</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HC Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy control subjects will participate in fMRI assessments only</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for reducing risk behaviors</intervention_name>
    <description>Cognitive Behavioral Therapy to reduce risk behaviors and increase risk perception that combines a standardised face-to-face group therapy before discharge from in-patient treatment and a standardised ecological momentary intervention delivered by mobile phones during the four weeks after discharge. For SZ the target risk behavior is medication non-adherence and for AUD and AUD &amp; SZ it is alcohol use.</description>
    <arm_group_label>AUD &amp; SZ Intervention</arm_group_label>
    <arm_group_label>AUD Intervention</arm_group_label>
    <arm_group_label>SZ Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for increasing non-risk behaviors</intervention_name>
    <description>Cognitive Behavioral Therapy to increase non-risk behaviors that combines a standardised face-to-face group therapy before discharge from in-patient treatment and a standardised ecological momentary intervention delivered by mobile phones during the four weeks after discharge. In this control intervention for patient groups the target behavior is cognitive exercises.</description>
    <arm_group_label>AUD &amp; SZ Control</arm_group_label>
    <arm_group_label>AUD Control</arm_group_label>
    <arm_group_label>SZ Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  for patient groups: fulfilling the diagnostic criteria for AUD or SZ or both&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        for patient groups and healthy control group:&#xD;
&#xD;
          -  no sufficient command of German language&#xD;
&#xD;
          -  neurological disorder for patient groups:&#xD;
&#xD;
          -  acute psychotic episode&#xD;
&#xD;
          -  acute suicidality or not distanced from self-harming behaviors&#xD;
&#xD;
          -  other substance use disorder (exception: nicotine and caffeine use disorders) for&#xD;
             healthy control group:&#xD;
&#xD;
          -  absence of any psychiatric diagnosis (exception: nicotine and caffeine use disorders)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Odenwald, Dr.</last_name>
    <phone>+49 7531 884621</phone>
    <email>michael.odenwald@uni-konstanz.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniela Mier, Prof. Dr.</last_name>
    <phone>+49 7531 884672</phone>
    <email>daniela.mier@uni-konstanz.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Konstanz, Research Ward</name>
      <address>
        <city>Konstanz</city>
        <zip>78464</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael G Odenwald, Dr rer. nat.</last_name>
      <phone>+49-7531-88-0</phone>
      <phone_ext>4621</phone_ext>
      <email>michael.odenwald@uni-konstanz.de</email>
    </contact>
    <contact_backup>
      <last_name>Anna Becker, Dr. med.</last_name>
      <phone>+49-7531-88-0</phone>
      <phone_ext>4618</phone_ext>
      <email>anna.2.becker@uni-konstanz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Alexander Wolber, MA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natascha Büchele, MA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Klepper S, Odenwald M, Rösner S, Senn S, Menning H, Pereyra-Kröll D, Rockstroh B. Experience-Induced Change of Alcohol-Related Risk Perception in Patients with Alcohol Use Disorders. Front Psychol. 2017 Nov 13;8:1967. doi: 10.3389/fpsyg.2017.01967. eCollection 2017.</citation>
    <PMID>29180975</PMID>
  </reference>
  <reference>
    <citation>Gollwitzer P, Oettingen G (2011). Planning promotes goal striving. In: KD Vohs, RF Baumeister (Eds.), Handbook of Self-Regulation: Research, Theory, and Applications (2nd edition, chapter 9, pp. 162 - 184). The Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Marlatt GA, Donovan, DM. Relapse Prevention. 2nd edition. The Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Miller R, Rollnick S (2013) Motivational Interviewing. 3rd edition. The Guilford Press.</citation>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 22, 2021</study_first_submitted>
  <study_first_submitted_qc>July 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Konstanz</investigator_affiliation>
    <investigator_full_name>Michael Odenwald</investigator_full_name>
    <investigator_title>Chief Psychologist Research Ward</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made available upon request ensuring the data protection laws are fulfilled</ipd_description>
    <ipd_time_frame>6 months after publication</ipd_time_frame>
    <ipd_access_criteria>will be defined according to legal requirements</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

